# TOLMAR

> TOLMAR is a VC fund in Fort Collins backing Health Care and Medical Device. See 2 investments, round sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: Fort Collins, United States
- Total investments: 2
- Last investment: Jun 2026
- Lead investor: 100%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/company/tolmar.
- Website: http://tolmar.com

TOLMAR is a northern Colorado based pharmaceutical research, development, manufacturing and commercial operations company. TOLMAR develops and manufacturers both proprietary and generic pharmaceutical products with specific focus in therapeutic areas of dental, dermatology, and oncology products.

## Contacts

5 contacts available for TOLMAR. Shizune tracks 4 team members at TOLMAR. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/tolmar?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 1 | 50% |
| Medical Device | 1 | 50% |
| Pharmaceutical | 1 | 50% |

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Post-IPO Equity | 1 | 50% |
| Venture - Series Unknown | 1 | 50% |

### Country

| Country | Investments | Share |
| --- | --- | --- |
| Israel | 1 | 50% |
| Finland | 1 | 50% |

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Anil D'souza | Chief Executive Officer | 0 | https://shizune.co/investors/profile/anil-d-souza-b09a |
| Gerald Wallner | Data Integrity Manager | 0 | https://shizune.co/investors/profile/gerald-wallner |
| Parker Schabel | Director of Strategy and Planning | 0 | https://shizune.co/investors/profile/parker-schabel |
| Ryan Turncliff | Vice President Clinical Development | 0 | https://shizune.co/investors/profile/ryan-turncliff |

## Investments

| Company | Description | Round size | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Alpha Tau Medical | Alpha Tau Medical is an Israeli medical device company that focuses on research, development and commercialization of Alpha DaRT (Diffusing Alpha-emitters Radiation Therapy) for the treatment of solid cancer. The Alpha DaRT technology was developed in 2003 at Tel Aviv University.Since then, numerous preclinical trials have found the technology tobe effective and safe for various indications and anatomic areas.The findings were published in 12 papers in peer-reviewed scientific journals. Today, the company is running its first clinical trial with very promising preliminary results. | $20M | Post-IPO Equity | Jun 03, 2026 | https://www.alphatau.com |
| DelSiTech | DelSiTech is a leading technology specialist in biodegradable silica-based controlled release of small molecule drugs, biopharmaceuticals and viral vectors. they focus on parenteral and local administration of drug products. | $10.9M | Venture - Series Unknown | Jan 16, 2024 | http://www.delsitech.com/ |

2 of 2 investments shown.

## Co-investors
- [DRW Venture Capital](https://shizune.co/investors/profile/drw-venture-capital) — VC Fund, 1 deal together

## Similar investors

### Similar industry
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [SOSV](https://shizune.co/investors/profile/sosv) — VC Fund

### Similar stage
- [RA Capital Management](https://shizune.co/investors/profile/ra-capital-management) — VC Fund
- [KB Securities](https://shizune.co/investors/profile/kb-securities) — VC Fund
- [Frazier Healthcare Partners](https://shizune.co/investors/profile/frazier-healthcare-ventures) — VC Fund

### Similar country
- [Business Finland](https://shizune.co/investors/profile/tekes) — VC Fund
- [Lifeline Ventures](https://shizune.co/investors/profile/lifeline-ventures) — VC Fund
- [Tesi](https://shizune.co/investors/profile/tesi) — VC Fund

## Featured in investor lists
- [Health Care VC Funds in Finland](https://shizune.co/investors/health-care-vc-funds-finland)

## FAQ

### What does TOLMAR invest in?

TOLMAR invests primarily in Health Care, Medical Device and Pharmaceutical startups, most often at Post-IPO Equity and Venture - Series Unknown stage. Most of the 2 investments tracked by Shizune back companies in Israel. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact TOLMAR?

Public channels for TOLMAR include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at TOLMAR?

The team at TOLMAR includes Anil D'souza (Chief Executive Officer), Gerald Wallner (Data Integrity Manager) and Parker Schabel (Director of Strategy and Planning). The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co